Detalhe da pesquisa
1.
DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype.
Biomarkers
; 18(6): 516-24, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23875912
2.
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
Lancet Oncol
; 11(8): 753-62, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20619739
3.
PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer.
Clin Cancer Res
; 15(9): 3184-8, 2009 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19366826
4.
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study.
Clin Cancer Res
; 14(18): 5869-76, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18794099
5.
Single Nucleotide Polymorphism (rs4932178) in the P1 Promoter of FURIN Is Not Prognostic to Colon Cancer.
Biomed Res Int
; 2015: 321276, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26137475
6.
Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis.
J Mol Diagn
; 14(3): 187-91, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22414609
7.
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.
J Clin Oncol
; 28(3): 466-74, 2010 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20008640
8.
Clinical biomarkers in oncology: focus on colorectal cancer.
Mol Diagn Ther
; 13(2): 103-14, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19537845
9.
Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.
PLoS One
; 4(11): e7746, 2009 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19888477
10.
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab.
J Clin Oncol
; 27(30): 5068-74, 2009 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19738126